| Application no. and date | 16160637.1 (espacenet) (Federated) (European Patent Register), 20150109 | | Patent/reg. no. and date | DK/EP 3069735, 20180314 | | Publication date | 20160921 | | Priority no. and date | EP 14150791, 20140110, EP 14188450, 20141010 | | EP pub. no. and date |
EP 3069735 20160921 | | Effective date | | | Applicant/owner | Byondis B.V., Microweg 22
6545 CM Nijmegen, NL | | Applicant ref. no. | 161453 | | Inventor | Beusker, Patrick Henry, Synthon Biopharmaceuticals B.V.
Microweg 22
6545 CM Nijmegen, NL,
DOKTER, Willem, Synthon Biopharmaceuticals B.V.
Microweg 22
6545 CM Nijmegen, NL,
GOEDINGS, Peter Johannes, Synthon Biopharmaceuticals B.V.
Microweg 22
6545 CM Nijmegen, NL,
VERHEIJDEN, Gijsbertus Franciscus Maria, Synthon Biopharmaceuticals B.V.
Microweg 22
6545 CM Nijmegen, NL | | Representative | AWA Denmark A/S, Strandgade 56, 1401 København K, DK | | Opponent | | | IPC Class | A61K 47/50 (2017.01) , A61P 35/00 (2006.01) | | Title | DUOCARMYCIN ADCS TIL ANVENDELSE VED BEHANDLING AF BLÆRECANCER | | Int. application no. | | | Int. publication no. | | | Related patent (certificate) | | | Status | DK/EP patent | | Pædiatrisk forlængelse | - | | Udløbsdato for pædiatrisk forlængelse | - |
|
